True North invests ₹536 crore in Biocon arm
The private equity firm’s investment values Biocon Biologics at about $3 billion on a pre-money equity basis.
kiran mazumdar shaw
January 2020
November 2019
October 2019
September 2019
August 2019
July 2019
Fortune India 500: Why are there so few women leaders?
Only around 6% companies on the Fortune India 500 list are managed by women.
MPW Summit 2019: Celebrating women power
The Fortune India MPW summit brings some of India’s biggest women executives together to discuss ideas and issues related to gender, women in the workplace, the economy, and the society at large.
Biocon’s biologics portfolio comes into its own
Bengaluru-based Biocon’s portfolio of biologic drugs has grown rapidly in the last five years and the company wants it to be a $1 billion business by 2022.
Inside the issue: Most Powerful Women
Zia Mody, co-founder, AZB & Partners, tops this year’s Most Powerful Women in Business list, Kiran Mazumdar-Shaw, India’s biotech queen, is at No. 2. Here’s more about the list.
B.R. Shetty: Prescribing growth
B.R. Shetty plans to pump in billions of dollars as part of his plan to open 20,000 hospital beds in India over the next 10 years. Given the churn in the healthcare sector, will he succeed?
Most Powerful Women 2019: Blazing a trail
Editor’s letter from September 15 - December 14, 2019 issue of the magazine
The long road ahead
The government aims to turn India into a $5-trillion economy in the next five years, but it has to cross several hurdles along the way.
V.G. Siddhartha: Death of an eternal optimist
The Café Coffee Day founder’s death has shocked business leaders, who considered him to be a resilient entrepreneur and an optimist.
Good blueprint, but gaps remain: India Inc.
Focus on infra, housing, financial services, labour reforms welcome; but concerns remain on corporate tax, ability to meet disinvestment target.
